He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed semaglutide had a 50% higher risk of being diagnosed with a hair-loss condition compared to those prescribed Contrave. That risk was twice as high for women as for men.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.

The FBI is warning about counterfeit weight loss drugs being sold that claim to have semaglutide, the key ingredient in Ozempic and Wegovy.

The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide, the active ingredient in Ozempic and Wegovy, two prescription medications used for weight loss.